Evaluation and performance of arccheck and film using gamma criteria in pre-treatment quality assurance of stereotactic ablative radiotherapy

Aim: The aim of this study is to assess the use of ArcCHECK (AC) as an alternative method to replace film dosimetry for pre-treatment quality assurance (QA) of three-dimensional conformal radiation therapy, intensity-modulated radiation therapy (IMRT), and volumetric-modulated arc therapy (VMAT) ste...

Full description

Bibliographic Details
Main Authors: Prabhakar Ramachandran, Abdulrahman Tajaldeen, David Taylor, Derrick Wanigaratne, Karl Roozen, Moshi Geso
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2017-01-01
Series:Journal of Medical Physics
Subjects:
Online Access:http://www.jmp.org.in/article.asp?issn=0971-6203;year=2017;volume=42;issue=4;spage=251;epage=257;aulast=Ramachandran
id doaj-cc513ce504b741c4b2ce82f3571337e3
record_format Article
spelling doaj-cc513ce504b741c4b2ce82f3571337e32020-11-24T23:37:20ZengWolters Kluwer Medknow PublicationsJournal of Medical Physics0971-62031998-39132017-01-0142425125710.4103/jmp.JMP_132_16Evaluation and performance of arccheck and film using gamma criteria in pre-treatment quality assurance of stereotactic ablative radiotherapyPrabhakar RamachandranAbdulrahman TajaldeenDavid TaylorDerrick WanigaratneKarl RoozenMoshi GesoAim: The aim of this study is to assess the use of ArcCHECK (AC) as an alternative method to replace film dosimetry for pre-treatment quality assurance (QA) of three-dimensional conformal radiation therapy, intensity-modulated radiation therapy (IMRT), and volumetric-modulated arc therapy (VMAT) stereotactic ablative radiotherapy (SABR) treatment plans. Materials and Methods: Twenty-five patients with a varied diagnosis of lung, spine, sacrum, sternum, ribs, scapula, and femur undergoing SABR were selected for this study. Pre-treatment QA was performed for all the patients using ionization chamber and film dosimetry. Measurements were also carried out on an AC phantom. The planned and measured doses from the AC device and EBT3 films were compared using four different gamma criteria: 2%/2 mm, 3%/2 mm, 3%/1 mm, and 3%/3 mm. Results: The mean gamma passing rates at 3%/3 mm for all non-spine SABR cases were 98.79 ± 0.96 and 99.27 ± 1.03 with AC and films, respectively. The mean passing rates at 3%/2 mm for AC and films were 98.76 ± 0.42 and 99.43 ± 0.27 respectively for spine VMAT SABR, and 87.15 ± 2.45 and 99.79 ± 0.14 respectively for spine IMRT SABR. In the case of spine tumors, the gamma criterion was tightened due to the proximity of spinal cord to the planning target volume. Our results show that AC provides good results for all VMAT SABR plans. Conclusion: The AC results at 3%/3 mm were in good agreement with film dosimetry for most cases. We observed a significant reduction in QA time on using AC for SABR QA. This study showed that AC results are comparable to film dosimetry for all studied sites except for spine IMRT SABR.http://www.jmp.org.in/article.asp?issn=0971-6203;year=2017;volume=42;issue=4;spage=251;epage=257;aulast=RamachandranArcCHECKEBT3 filmsstereotactic ablative radiotherapy
collection DOAJ
language English
format Article
sources DOAJ
author Prabhakar Ramachandran
Abdulrahman Tajaldeen
David Taylor
Derrick Wanigaratne
Karl Roozen
Moshi Geso
spellingShingle Prabhakar Ramachandran
Abdulrahman Tajaldeen
David Taylor
Derrick Wanigaratne
Karl Roozen
Moshi Geso
Evaluation and performance of arccheck and film using gamma criteria in pre-treatment quality assurance of stereotactic ablative radiotherapy
Journal of Medical Physics
ArcCHECK
EBT3 films
stereotactic ablative radiotherapy
author_facet Prabhakar Ramachandran
Abdulrahman Tajaldeen
David Taylor
Derrick Wanigaratne
Karl Roozen
Moshi Geso
author_sort Prabhakar Ramachandran
title Evaluation and performance of arccheck and film using gamma criteria in pre-treatment quality assurance of stereotactic ablative radiotherapy
title_short Evaluation and performance of arccheck and film using gamma criteria in pre-treatment quality assurance of stereotactic ablative radiotherapy
title_full Evaluation and performance of arccheck and film using gamma criteria in pre-treatment quality assurance of stereotactic ablative radiotherapy
title_fullStr Evaluation and performance of arccheck and film using gamma criteria in pre-treatment quality assurance of stereotactic ablative radiotherapy
title_full_unstemmed Evaluation and performance of arccheck and film using gamma criteria in pre-treatment quality assurance of stereotactic ablative radiotherapy
title_sort evaluation and performance of arccheck and film using gamma criteria in pre-treatment quality assurance of stereotactic ablative radiotherapy
publisher Wolters Kluwer Medknow Publications
series Journal of Medical Physics
issn 0971-6203
1998-3913
publishDate 2017-01-01
description Aim: The aim of this study is to assess the use of ArcCHECK (AC) as an alternative method to replace film dosimetry for pre-treatment quality assurance (QA) of three-dimensional conformal radiation therapy, intensity-modulated radiation therapy (IMRT), and volumetric-modulated arc therapy (VMAT) stereotactic ablative radiotherapy (SABR) treatment plans. Materials and Methods: Twenty-five patients with a varied diagnosis of lung, spine, sacrum, sternum, ribs, scapula, and femur undergoing SABR were selected for this study. Pre-treatment QA was performed for all the patients using ionization chamber and film dosimetry. Measurements were also carried out on an AC phantom. The planned and measured doses from the AC device and EBT3 films were compared using four different gamma criteria: 2%/2 mm, 3%/2 mm, 3%/1 mm, and 3%/3 mm. Results: The mean gamma passing rates at 3%/3 mm for all non-spine SABR cases were 98.79 ± 0.96 and 99.27 ± 1.03 with AC and films, respectively. The mean passing rates at 3%/2 mm for AC and films were 98.76 ± 0.42 and 99.43 ± 0.27 respectively for spine VMAT SABR, and 87.15 ± 2.45 and 99.79 ± 0.14 respectively for spine IMRT SABR. In the case of spine tumors, the gamma criterion was tightened due to the proximity of spinal cord to the planning target volume. Our results show that AC provides good results for all VMAT SABR plans. Conclusion: The AC results at 3%/3 mm were in good agreement with film dosimetry for most cases. We observed a significant reduction in QA time on using AC for SABR QA. This study showed that AC results are comparable to film dosimetry for all studied sites except for spine IMRT SABR.
topic ArcCHECK
EBT3 films
stereotactic ablative radiotherapy
url http://www.jmp.org.in/article.asp?issn=0971-6203;year=2017;volume=42;issue=4;spage=251;epage=257;aulast=Ramachandran
work_keys_str_mv AT prabhakarramachandran evaluationandperformanceofarccheckandfilmusinggammacriteriainpretreatmentqualityassuranceofstereotacticablativeradiotherapy
AT abdulrahmantajaldeen evaluationandperformanceofarccheckandfilmusinggammacriteriainpretreatmentqualityassuranceofstereotacticablativeradiotherapy
AT davidtaylor evaluationandperformanceofarccheckandfilmusinggammacriteriainpretreatmentqualityassuranceofstereotacticablativeradiotherapy
AT derrickwanigaratne evaluationandperformanceofarccheckandfilmusinggammacriteriainpretreatmentqualityassuranceofstereotacticablativeradiotherapy
AT karlroozen evaluationandperformanceofarccheckandfilmusinggammacriteriainpretreatmentqualityassuranceofstereotacticablativeradiotherapy
AT moshigeso evaluationandperformanceofarccheckandfilmusinggammacriteriainpretreatmentqualityassuranceofstereotacticablativeradiotherapy
_version_ 1725520275890503680